Xpeng (XPEV) has had the highest return since January 1, 2025 by a large-cap US stock, returning 75%.
| ASSET | % RETURN |
|---|---|
Xpeng (XPEV) | 75.02% |
Hims Hers Health (HIMS) | 65.23% |
Intracellular Th (ITCI) | 55.99% |
Alibaba (BABA) | 55.01% |
CVS Health (CVS) | 45.7% |
Banco Santander SA ADR (SAN) | 44.74% |
Dutch Bros (BROS) | 44.58% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 41.69% |
Lloyds Banking Group PLC ADR (LYG) | 36.3% |
BeiGene (ONC) | 34.54% |
Gold Fields Ltd ADR (GFI) | 33.5% |
Royalty Pharma (RPRX) | 33.4% |
Spotify Technology (SPOT) | 33.13% |
Futu (FUTU) | 31.85% |
Philip Morris International (PM) | 30.86% |
Tapestry (TPR) | 28.15% |
ArcelorMittal SA ADR (MT) | 27.51% |
Elbit Systems (ESLT) | 27.43% |
Doximity (DOCS) | 26.99% |
Starbucks (SBUX) | 26.75% |
Cheniere Energy Partners (CQP) | 25.95% |
Nutanix (NTNX) | 25.71% |
Deutsche Bank (DB) | 25.47% |
Gilead Sciences (GILD) | 25.23% |
Cloudflare (NET) | 24.81% |
Large-cap stocks are treated as having a market cap of $10B+.
